Clinical trial
Efficacy of Quetiapine in the Treatment of Patients With Schizophrenia and a…
NCT00156715 · Dartmouth-Hitchcock Medical Center, Other · Completed
Key facts
| NCT number | NCT00156715 |
|---|---|
| Title | Efficacy of Quetiapine in the Treatment of Patients With Schizophrenia and a Comorbid Substance Use Disorder |
| Official title | Efficacy of Quetiapine in Treating Patients With Active Substance Use Disorder and Schizophrenia |
| Lead sponsor | Dartmouth-Hitchcock Medical Center, Other |
| Collaborators | Augusta University AstraZeneca Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia, Schizoaffective Disorder, Psychotic Disorder, Substance Abuse, Alcohol Abuse |
| Intervention type | Drug |
| Interventions | Quetiapine |
| Enrollment | 23 |
| Start date | Mar 1, 2004 |
| Primary completion | Sep 1, 2006 |
| Completion | Oct 1, 2008 |
| First posted | Sep 12, 2005 |
| Last update posted | Mar 14, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: